Chief Operating Officer

Senior Vice President Medical Affairs

Transcript : Vera Therapeutics, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 09

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 5, 2025

Vera Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4)

Vera Therapeutics to Participate at Upcoming September 2025 Investor Conferences

Senior Director, Government Accounts & Policy

Vera Therapeutics is a late clinical-stage biotechnology company focused on developing treatments for serious immunological diseases. The Senior Director, Government Accounts & Policy will oversee government payer coverage for the company's product portfolio, collaborating with various teams to ensure access to promoted products within government payer programs.

Sign up with Google

Sign in with Google